These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 24325278)

  • 1. Bioactive glass BAG-S53P4 for the adjunctive treatment of chronic osteomyelitis of the long bones: an in vitro and prospective clinical study.
    Drago L; Romanò D; De Vecchi E; Vassena C; Logoluso N; Mattina R; Romanò CL
    BMC Infect Dis; 2013 Dec; 13():584. PubMed ID: 24325278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro antibacterial activity of bioactive glass S53P4 on multiresistant pathogens causing osteomyelitis and prosthetic joint infection.
    Cunha MT; Murça MA; Nigro S; Klautau GB; Salles MJC
    BMC Infect Dis; 2018 Apr; 18(1):157. PubMed ID: 29614973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Use of Bioactive Glass S53P4 as Bone Graft Substitute in the Treatment of Chronic Osteomyelitis and Infected Non-Unions - a Retrospective Study of 50 Patients.
    Malat TA; Glombitza M; Dahmen J; Hax PM; Steinhausen E
    Z Orthop Unfall; 2018 Apr; 156(2):152-159. PubMed ID: 29665602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioactive glass S53P4 as bone graft substitute in treatment of osteomyelitis.
    Lindfors NC; Hyvönen P; Nyyssönen M; Kirjavainen M; Kankare J; Gullichsen E; Salo J
    Bone; 2010 Aug; 47(2):212-8. PubMed ID: 20624692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial activity and resistance selection of different bioglass S53P4 formulations against multidrug resistant strains.
    Drago L; De Vecchi E; Bortolin M; Toscano M; Mattina R; Romanò CL
    Future Microbiol; 2015; 10(8):1293-9. PubMed ID: 26228640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibacterial Bioactive Glass, S53P4, for Chronic Bone Infections - A Multinational Study.
    Lindfors N; Geurts J; Drago L; Arts JJ; Juutilainen V; Hyvönen P; Suda AJ; Domenico A; Artiaco S; Alizadeh C; Brychcy A; Bialecki J; Romanò CL
    Adv Exp Med Biol; 2017; 971():81-92. PubMed ID: 28050878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioactive glass S53P4 to fill-up large cavitary bone defect after acute and chronic osteomyelitis treated with antibiotic-loaded cement beads: A prospective case series with a minimum 2-year follow-up.
    Kojima KE; de Andrade E Silva FB; Leonhardt MC; de Carvalho VC; de Oliveira PRD; Lima ALLM; Roberto Dos Reis P; Silva JDS
    Injury; 2021 Jul; 52 Suppl 3():S23-S28. PubMed ID: 34116851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of antibacterial bioactive glass S53P4 against S. aureus biofilms grown on titanium discs in vitro.
    Coraça-Huber DC; Fille M; Hausdorfer J; Putzer D; Nogler M
    J Orthop Res; 2014 Jan; 32(1):175-7. PubMed ID: 24108602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilisation of bioactive glass S53P4 inside an induced membrane for severe bone defect with high risk of infection: a multi-center preliminary experience.
    Aurégan JC; Villain B; Glombitza M; Blokhuis T; Heinänen M; Bégué T
    Injury; 2022 Oct; 53 Suppl 2():S13-S19. PubMed ID: 35871084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The in vitro antibacterial effect of S53P4 bioactive glass and gentamicin impregnated polymethylmethacrylate beads.
    Gergely I; Zazgyva A; Man A; Zuh SG; Pop TS
    Acta Microbiol Immunol Hung; 2014 Jun; 61(2):145-60. PubMed ID: 24939683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial activity of bioactive glass S53P4 against representative microorganisms causing osteomyelitis - Real-time assessment by isothermal microcalorimetry.
    Gonzalez Moreno M; Butini ME; Maiolo EM; Sessa L; Trampuz A
    Colloids Surf B Biointerfaces; 2020 May; 189():110853. PubMed ID: 32058256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcomes and complications of S53P4 bioactive glass in chronic osteomyelitis and septic non-unions: a retrospective single-center study.
    Gatti SD; Gaddi D; Turati M; Leone G; Arts JJ; Pessina F; Carminati M; Zatti G; De Rosa L; Bigoni M
    Eur J Clin Microbiol Infect Dis; 2024 Mar; 43(3):489-499. PubMed ID: 38195783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bilateral tibial Brodie's abscess in a young patient treated with BAG-S53P4: case report.
    Cossio A; Graci J; Lombardo AS; Turati M; Melzi ML; Bigoni M; Zatti G
    Ital J Pediatr; 2019 Jul; 45(1):91. PubMed ID: 31349859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BAG-S53P4 as bone graft extender and antimicrobial activity against gentamicin- and vancomycin-resistant bacteria.
    Bortolin M; Romanò CL; Bidossi A; Vecchi E; Mattina R; Drago L
    Future Microbiol; 2018 Apr; 13():525-533. PubMed ID: 29521127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical applications of Bioactive glass S53P4 in bone infections: a systematic review.
    Bigoni M; Turati M; Zanchi N; Lombardo AS; Graci J; Omeljaniuk RJ; Zatti G; Gaddi D
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(2 Suppl):240-251. PubMed ID: 30977891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiofilm agents against MDR bacterial strains: is bioactive glass BAG-S53P4 also effective?
    Bortolin M; De Vecchi E; Romanò CL; Toscano M; Mattina R; Drago L
    J Antimicrob Chemother; 2016 Jan; 71(1):123-7. PubMed ID: 26462989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of the use of bioactive glass S53P4 and antibiotic-loaded calcium-based bone substitutes in the treatment of chronic osteomyelitis: a retrospective comparative study.
    Romanò CL; Logoluso N; Meani E; Romanò D; De Vecchi E; Vassena C; Drago L
    Bone Joint J; 2014 Jun; 96-B(6):845-50. PubMed ID: 24891588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regeneration of Cystic Bone Cavities and Bone Defects With Bioactive Glass S53P4 in the Upper and Lower Jaws.
    Stoor P; Apajalahti S; Kontio R
    J Craniofac Surg; 2017 Jul; 28(5):1197-1205. PubMed ID: 28538076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of different bioactive glass S53P4 formulations in biofilm eradication and the impact of pH and osmotic pressure.
    Müller N; Kollert M; Trampuz A; Gonzalez Moreno M
    Colloids Surf B Biointerfaces; 2024 Jul; 239():113940. PubMed ID: 38744081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro antibiofilm activity of bioactive glass S53P4.
    Drago L; Vassena C; Fenu S; De Vecchi E; Signori V; De Francesco R; Romanò CL
    Future Microbiol; 2014; 9(5):593-601. PubMed ID: 24957087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.